• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Pharma Pulse 8/14/24: The Specifics of Specialty Lite, Intermittent Fasting May Offset Alzheimer's & more

News
Article

The latest news for pharma industry insiders.

The Specifics of Specialty Lite

In the final part of his Pharma Commerce video interview, Josh Marsh, Vice President and General Manager of Cardinal Health Sonexus Access and Patient Support, defines the qualifying characteristics of a specialty lite product, and summarizes the main points of his Asembia panel.

Study Finds Intermittent Fasting May Offset Alzheimer Disease Risk, Support Treatment Goals

The study may serve as a foundation for future investigation regarding dietary recommendations to support the treatment of Alzheimer disease.

Brands Love Influencers (Until Politics Get Involved)

Marketing firms are using artificial intelligence to help analyze influencers and predict whether they will opine about the election.

Modern Health Selected To Prestigious Inc. 5000 List of America’s Fastest-Growing Private Companies

Inc. revealed that Modern Health has been selected to the 2024 Inc. 5000, its annual list of the fastest-growing private companies in America. The prestigious ranking provides a data-driven look at the most successful companies within the economy’s most dynamic segment—its independent, entrepreneurial businesses. Microsoft, Meta, Chobani, Under Armour, Timberland, Oracle, Patagonia, and many other household-name brands gained their first national exposure as honorees on the Inc. 5000.

Organon on LinkedIn

At Organon, we believe a healthy pregnancy and childbirth are cornerstones of women’s health. Yet, significant barriers exist to necessary maternal health services in maternity care deserts.

Dr. Charlotte Owens, MD, FACOG, Head of Medical Affairs & Outcomes Research at Organon & an OB/GYN, recently spoke with Pharmaceutical Executive to shed light on the individual and broader impacts of a lack of investment in high-quality maternal care. Read below for a few key takeaways from the conversation:

🤰 𝗧𝗵𝗲𝗿𝗲’𝘀 𝗮 𝗺𝗮𝘁𝗲𝗿𝗻𝗮𝗹 𝗰𝗮𝗿𝗲 𝗰𝗿𝗶𝘀𝗶𝘀 𝘁𝗵𝗮𝘁 𝗺𝘂𝘀𝘁 𝗯𝗲 𝘂𝗿𝗴𝗲𝗻𝘁𝗹𝘆 𝗮𝗱𝗱𝗿𝗲𝘀𝘀𝗲𝗱.
Birth complications remain a significant challenge for women in the U.S. and globally, which may be due in part to a lack of access in areas where hospitals and birthing centers do not have the proper obstetric care.

👩 👨 👵 𝗧𝗵𝗲 𝗶𝗺𝗽𝗮𝗰𝘁 𝗼𝗳 𝗽𝗼𝗼𝗿 𝗺𝗮𝘁𝗲𝗿𝗻𝗮𝗹 𝗰𝗮𝗿𝗲 𝗶𝘀 𝗳𝗮𝗿-𝗿𝗲𝗮𝗰𝗵𝗶𝗻𝗴 𝗮𝗻𝗱 𝗰𝗮𝗻 𝗶𝗺𝗽𝗮𝗰𝘁 𝘄𝗼𝗺𝗲𝗻, 𝗳𝗮𝗺𝗶𝗹𝗶𝗲𝘀 𝗮𝗻𝗱 𝘀𝗼𝗰𝗶𝗲𝘁𝗶𝗲𝘀 𝗳𝗼𝗿 𝗴𝗲𝗻𝗲𝗿𝗮𝘁𝗶𝗼𝗻𝘀 𝘁𝗼 𝗰𝗼𝗺𝗲.
Adverse outcomes for mothers extend beyond women and can have lasting social and economic effects on families and communities.

🤝 𝗔𝗱𝗱𝗿𝗲𝘀𝘀𝗶𝗻𝗴 𝗴𝗮𝗽𝘀 𝗶𝗻 𝘄𝗼𝗺𝗲𝗻’𝘀 𝗵𝗲𝗮𝗹𝘁𝗵 𝘄𝗶𝗹𝗹 𝗿𝗲𝗾𝘂𝗶𝗿𝗲 𝗮 𝘀𝘁𝗿𝗮𝘁𝗲𝗴𝗶𝗰, 𝗰𝗿𝗼𝘀𝘀-𝗰𝗼𝗹𝗹𝗮𝗯𝗼𝗿𝗮𝘁𝗶𝘃𝗲 𝗮𝗽𝗽𝗿𝗼𝗮𝗰𝗵 𝘁𝗼 𝗮𝗰𝗰𝗲𝗹𝗲𝗿𝗮𝘁𝗲 𝗹𝗼𝗻𝗴 𝗼𝘃𝗲𝗿𝗱𝘂𝗲 𝗽𝗿𝗼𝗴𝗿𝗲𝘀𝘀.
Organon is partnering with organizations and governments globally to help reduce the gaps in women’s health needs, including in maternal health, and to support research, funding and community action.

#GenderEquity #WomensHealth

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs